Population-based, case-control-family design to investigate genetic and environmental influences on melanoma risk

American Journal of Epidemiology

Volumn 170, Issue 12, 2009, Pages 1541-1554

  Cust, Anne E ^a   Schmid, Helen ^b   Maskiell, Judith A ^a   Jetann, Jodie ^c   Ferguson, Megan ^c   Holland, Elizabeth A ^b   Agha Hamilton, Chantelle ^b   Jenkins, Mark A ^a   Kelly, John ^d   Kefford, Richard F ^b   Giles, Graham G ^e   Armstrong, Bruce K ^f   Aitken, Joanne F ^c   Hopper, John L ^a   Mann, Graham J ^b  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

^c VIERTEL CENTRE FOR RESEARCH IN CANCER CONTROL   (Australia)

^d ALFRED HOSPITAL   (Australia)

^e CANCER EPIDEMIOLOGY CENTRE   (Australia)

^f UNIVERSITY OF SYDNEY   (Australia)

Author keywords

Case control studies; Environmental exposure; Family; Genetic predisposition to disease; Melanoma; Risk factors

Indexed keywords

CANCER; DISEASE CONTROL; DISEASE INCIDENCE; ENVIRONMENTAL FACTOR; FAMILY STRUCTURE; GENETIC STRUCTURE; HEALTH RISK; PHENOTYPE; PIGMENT; RADIATION EXPOSURE; RISK FACTOR; SKIN DISORDER; ULTRAVIOLET RADIATION;

ADULT; ARTICLE; CANCER INCIDENCE; CANCER RISK; CONTROLLED STUDY; ECOLOGICAL GENETICS; ENVIRONMENTAL FACTOR; FEMALE; HEREDITY; HIGH RISK POPULATION; HISTOPATHOLOGY; HUMAN; LIFESPAN; MAJOR CLINICAL STUDY; MALE; MELANOMA; PHENOTYPE; PIGMENTATION; SKIN EXAMINATION; SUN EXPOSURE; ULTRAVIOLET RADIATION;

ADOLESCENT; ADULT; AGE FACTORS; AUSTRALIA; CASE-CONTROL STUDIES; ENVIRONMENT; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; MELANOMA; MIDDLE AGED; PHENOTYPE; RESIDENCE CHARACTERISTICS; RISK FACTORS; SKIN NEOPLASMS; SOCIOECONOMIC FACTORS; SUNLIGHT; YOUNG ADULT;

AUSTRALASIA; AUSTRALIA;

EID: 71549124713     PISSN: 00029262     EISSN: 14766256     Source Type: Journal    
DOI: 10.1093/aje/kwp307     Document Type: Article

References (61)

1. Hopper JL, Bishop DT, Easton DF. Population-based family studies in genetic epidemiology. Lancet. 2005;366(9494):1397-1406.
2. Lens MB, Dawes M. Global perspectives of contemporary epidemiological trends of cutaneous malignant melanoma. Br J Dermatol. 2004;150(2):179-185.
3. Australian Institute of Health and Welfare (AIHW) & Australasian Association of Cancer Registries (AACR). Cancer in Australia: An Overview, 2006. Canberra, Australia: AIHW; 2007.
4. Australian Institute of Health and Welfare (AIHW) & Australasian Association of Cancer Registries (AACR). Cancer in Australia, 2001. Canberra, Australia: AIHW; 2004.
5. Curtin JA, Fridlyand J, Kageshita T, et al. Distinct sets of genetic alterations in melanoma. N Engl J Med. 2005;353(20): 2135-2147.
6. Landi MT, Bauer J, Pfeiffer RM, et al. MC1R germline variants confer risk for BRAF-mutant melanoma. Science. 2006; 313(5786):521-522.
7. Whiteman DC, Watt P, Purdie DM, et al. Melanocytic nevi, solar keratoses, and divergent pathways to cutaneous melanoma. J Natl Cancer Inst. 2003;95(11):806-812.
8. Hayward NK. Genetics of melanoma predisposition. Onco-gene. 2003;22(20):3053-3062.
9. Box NF, Duffy DL, Chen W, et al. MC1R genotype modifies risk of melanoma in families segregating CDKN2A mutations. Am J Hum Genet. 2001;69(4):765-773.
10. Bishop DT, Demenais F, Goldstein AM, et al. Geographical variation in the penetrance of CDKN2A mutations for melanoma. J Natl Cancer Inst. 2002;94(12):894-903.
11. Brown KM, Macgregor S, Montgomery GW, et al. Common sequence variants on 20q11.22 confer melanoma susceptibility. Nat Genet. 2008;40(7):838-840.
12. Hopper JL, Chenevix-Trench G, Jolley DJ, et al. Design and analysis issues in a population-based, case-control-family study of the genetic epidemiology of breast cancer and the Co-operative Family Registry for Breast Cancer Studies (CFRBCS). J Natl Cancer Inst Monogr. 1999;1999(26): 95-100.
13. Australian Bureau of Statistics. Australian Demographic Statistics, March, 2008. Canberra, Australia: Australian Bureau of Statistics, 2008.
14. Australian Bureau of Statistics. Census, 2006. Canberra, Australia: Australian Bureau of Statistics, 2008.
15. Cannings C, Thompson EA. Ascertainment in the sequential sampling of pedigrees. Clin Genet. 1977;12(4):208-212.
16. Kricker A, Armstrong BK, Goumas C, et al. Ambient UV, personal sun exposure and risk of multiple primary melanomas. Cancer Causes Control. 2007;18(3):295-304.
17. Lee-Taylor J, Madronich S. Climatology of UV-A, UV-B, and Erythemal Radiation at the Earth's Surface, 1979-2000. Boulder, CO: National Center for Atmospheric Research; 2007.
18. English DR, MacLennan R, Rivers J, et al. Epidemiological Studies of Melanocytic Naevi: Protocol for Identifying and Recording Naevi. Lyon, France: International Agency for Research on Cancer; 1990. (IARC internal report no. 90/002).
19. Dwyer T, Blizzard L, Ashbolt R. Sunburn associated with increased number of nevi in darker as well as lighter skinned adolescents of northern European descent. Cancer Epidemiol Biomarkers Prev. 1995;4(8):825-830.
20. Leu M, Reilly M, Czene K. Evaluation of bias in familial risk estimates: a study of common cancers using Swedish population-based registers. J Natl Cancer Inst. 2008;100(18): 1318-1325.
21. Berwick M, Orlow I, Hummer AJ, et al. The prevalence of CDKN2A germ-line mutations and relative risk for cutaneous malignant melanoma: an international population-based study. Cancer Epidemiol Biomarkers Prev. 2006;15(8):1520-1525.
22. Weiss NS. Assessing the influence of a genetic characteristic on disease in the presence of a strong environmental etiology. Epidemiology. 2007;18(4):429-430.
23. Gies P, Roy C, Javorniczky J, et al. Global Solar UV Index: Australian measurements, forecasts and comparison with the UK. Photochem Photobiol. 2004;79(1):32-39.
24. Gandini S, Sera F, Cattaruzza MS, et al. Meta-analysis of risk factors for cutaneous melanoma. III. Family history, actinic damage and phenotypic factors. Eur J Cancer. 2005;41(14): 2040-2059.
25. Whiteman DC, Whiteman CA, Green AC. Childhood sun exposure as a risk factor for melanoma: a systematic review of epidemiologic studies. Cancer Causes Control. 2001;12(1): 69-82.
26. Galea S, Tracy M. Participation rates in epidemiologic studies. Ann Epidemiol. 2007;17(9):643-653.
27. Cardis E, Richardson L, Deltour I, et al. The INTERPHONE study: design, epidemiological methods, and description of the study population. Eur J Epidemiol. 2007;22(9):647-664.
28. de Vries E, Boniol M, Severi G, et al. Public awareness about risk factors could pose problems for case-control studies: the example of sunbed use and cutaneous melanoma. Eur
29. J Cancer. 2005;41(14):2150-2154.
30. Morimoto LM, White E, Newcomb PA. Selection bias in the assessment of gene-environment interaction in case-control studies. Am J Epidemiol. 2003;158(3):259-263.
31. Gandini S, Sera F, Cattaruzza MS, et al. Meta-analysis of risk factors for cutaneous melanoma. I. Common and atypical naevi. Eur J Cancer. 2005;41(1):28-44.
32. Armstrong BK, White E, Saracci R. Principles of Exposure Measurement in Epidemiology. Oxford, United Kingdom: Oxford University Press; 1992.
33. Parr CL, Hjartaker A, Laake P, et al. Parr et al. respond to ''Recall bias in melanoma.''. Am J Epidemiol. 2009;169(3): 271-272.
34. Kricker A, Armstrong BK, English DR, et al. A dose-response curve for sun exposure and basal cell carcinoma. Int J Cancer. 1995;60(4):482-488.
35. Vajdic CM, Kricker A, Giblin M, et al. Sun exposure predicts risk of ocular melanoma in Australia. Int J Cancer. 2002;101(2): 175-182.
36. Hughes AM, Armstrong BK, Vajdic CM, et al. Sun exposure may protect against non-Hodgkin lymphoma: a case-control study. Int J Cancer. 2004;112(5):865-871.
37. Kricker A, Vajdic CM, Armstrong BK. Reliability and validity of a telephone questionnaire for estimating lifetime personal sun exposure in epidemiologic studies. Cancer Epidemiol Biomarkers Prev. 2005;14(10):2427-2432.
38. English DR, Armstrong BK, Kricker A. Reproducibility of reported measurements of sun exposure in a case-control study. Cancer Epidemiol Biomarkers Prev. 1998;7(10): 857-863. (Pubitemid 28471572)
39. Rosso S, Miñarro R, Schraub S, et al. Reproducibility of skin characteristic measurements and reported sun exposure history. Int J Epidemiol. 2002;31(2):439-446.
40. Berwick M, Chen YT. Reliability of reported sunburn history in a case-control study of cutaneous malignant melanoma. Am J Epidemiol. 1995;141(11):1033-1037.
41. Veierød MB, Parr CL, Lund E, et al. Reproducibility of self-reported melanoma risk factors in a large cohort study of Norwegian women. Melanoma Res. 2008;18(1): 1-9.
42. Weinstock MA, Colditz GA, Willett WC, et al. Recall (report) bias and reliability in the retrospective assessment of melanoma risk. Am J Epidemiol. 1991;133(3):240-245.
43. Baxter AJ, Hughes MC, Kvaskoff M, et al. The Queensland Study of Melanoma: Environmental and Genetic Associations (Q-MEGA); study design, baseline characteristics, and repeatability of phenotype and sun exposure measures. Twin Res Hum Genet. 2008;11(2):183-196.
44. Aitken JF, Green A, MacLennan R, et al. Comparability of surrogate and self-reported information on melanoma risk factors. Br J Cancer. 1993;67(5):1036-1041.
45. Pfahlberg AB, Gefeller O. Errors in assessing risk factors for melanoma: lack of reproducibility is the minor problem. Melanoma Res. 2008;18(4):300-301.
46. Walter SD, Marrett LD, From L, et al. The association of cutaneous malignant melanoma with the use of sunbeds and sunlamps. Am J Epidemiol. 1990;131(2):232-243.
47. Parr CL, Hjarta°ker A, Laake P, et al. Recall bias in melanoma risk factors and measurement error effects: a nested case-control study within the Norwegian Women and Cancer Study. Am J Epidemiol. 2009;169(3):257-266.
48. Gefeller O. Invited commentary: recall bias in melanoma-much ado about almost nothing? Am J Epidemiol. 2009;169(3): 267-270.
49. Han J, Colditz GA, Hunter DJ. Risk factors for skin cancers: a nested case-control study within the Nurses' Health Study. Int J Epidemiol. 2006;35(6):1514-1521.
50. Aitken JF, Youl P, Green A, et al. Accuracy of case-reported family history of melanoma in Queensland, Australia. Melanoma Res. 1996;6(4):313-317.
51. Green A, Battistutta D. Incidence and determinants of skin cancer in a high-risk Australian population. Int J Cancer. 1990; 46(3):356-361.
52. Aitken JF, Green AC, MacLennan R, et al. The Queensland Familial Melanoma Project: study design and characteristics of participants. Melanoma Res. 1996;6(2):155-165.
53. Aitken J, Bain C, Ward M, et al. How accurate is self-reported family history of colorectal cancer? Am J Epidemiol. 1995; 141(9):863-871.
54. Murff HJ, Spigel DR, Syngal S. Does this patient have a family history of cancer? An evidence-based analysis of the accuracy of family cancer history. JAMA. 2004;292(12):1480-1489.
55. Witte JS, Gauderman WJ, Thomas DC. Asymptotic bias and efficiency in case-control studies of candidate genes and gene-environment interactions: basic family designs. Am J Epidemiol. 1999;149(8):693-705.
56. Cui JS, Spurdle AB, Southey MC, et al. Regressive logistic and proportional hazards disease models for within-family analyses of measured genotypes, with application to a CYP17 polymorphism and breast cancer. Genet Epidemiol. 2003;24(3): 161-172.
57. Jenkins MA, Croitoru ME, Monga N, et al. Risk of colorectal cancer in monoallelic and biallelic carriers of MYH mutations: a population-based case-family study. Cancer Epidemiol Biomarkers Prev. 2006;15(2):312-314.
58. Antoniou AC, Pharoah PD, McMullan G, et al. A comprehensive model for familial breast cancer incorporating BRCA1, BRCA2 and other genes. Br J Cancer. 2002;86(1):76-83.
59. Dite GS, Jenkins MA, Southey MC, et al. Familial risks, early-onset breast cancer, and BRCA1 and BRCA2 germline mutations. J Natl Cancer Inst. 2003;95(6):448-457.
60. Gail MH, Pee D, Carroll R. Kin-cohort designs for gene characterization. J Natl Cancer Inst Monogr. 1999;1999(26): 55-60.
61. Olsen CM, Zens MS, Stukel TA, et al. Nevus density and melanoma risk in women: a pooled analysis to test the divergent pathway hypothesis. Int J Cancer. 2009;124(4):937-944.